Meet With... Johnson & Johnson California Innovation Center

Oct 29 2013

Over the past few years, you’ve gotten a chance to know us at Janssen Labs and that’s given us an opportunity to interact with you and to think about what else you, the Innovator, needs to get your science to the patient. Janssen Labs is part of the Johnson & Johnson Family of Companies and through our engagement with you, we continue to evolve in an effort to better meet the needs of the Innovator and ultimately the patient. It is because of you that Johnson & Johnson created regional Innovation Centers that host a team of science and transaction experts whose goal is to find high potential early-stage (pre-clinical proof-of-concept) innovation and form custom business solutions around it to help accelerate the science to the patient. The California Innovation Center (IC) team has broad deal-making capabilities with the flexibility to adapt the deal structures to the science.

Our corporate venture group, Johnson & Johnson Development Corporation (JJDC), is also co-located in the California IC and can also fund great science in a more traditional way. Together our teams can provide you the best possible chance of taking your solution to the people who need it the most.

We’d like to invite you to meet the teams that call California home, Janssen Labs, the Johnson & Johnson California IC and JJDC, in person to learn more about how we can work with you. If you’re interested in an one-on-one meeting with any or all of these organizations, please send in an application. Leaders from all areas of the life science industry are encouraged to apply today!

10:30am | Registration & Networking
11:00am | Presentation and Q&A
11:45am | Networking Lunch
12:30-3:30pm | One-on-one Meetings*

*Companies must apply ahead of time and be approved for a one-on-one meeting. The application period ends October 15th. APPLY HERE

About JJIC
The California Innovation Center is home to a team of science and transaction experts who identify and build novel early stage collaborations with emerging companies, entrepreneurs and academic centers. This team has full and broad deal-making capabilities, with flexibility to adapt deal structures to match early-stage needs and opportunities, as well as establish novel collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. More information can be found here:

Program Fees
Presentation & Lunch Only
Free | General Public
Includes presentation, Q&A and lunch

One-on-One Meeting
Free | Apply
Includes one-on-one meeting only. Companies must have applied for a one-on-one meeting ahead of time. The application period ends on October 15th. Acceptance of a one-on-one meeting is not guaranteed as all applications must be approved. 

Registration to attend the presentation, lunch and optional tours will remain open until October 28th.

NOTE: All companies accepted for a one-on-one meeting will be notified of acceptance by by October 21st and emailed a specific link to pay the required registration fees online.

California Innovation Center Team
Thomas Gustafson | Cardiovascular & Metabolic Disease, IC
Adam Keeney | Head of Transactions & Partnerships, IC
Arturo Molina | Oncology Innovation, IC
Jackie Papkoff | Immunology Innovation, IC
Guy Seabrook | Neuroscience Innovation, IC
Jeff Calcagno | Venture Investments, JJDC
Asish Xavier | Venture Investments, JJDC
Kara Bortone | Head of Company Sourcing, Janssen Labs